Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Darbepoetin Alfa Risks Outweigh Benefits for Patients With CKD, Diabetes, and Anaemia: Presented at Renal Week 2009 - (DGDispatch)
    Fenofibrate May Protect Diabetics Against Loss of Renal Function: Presented at Renal Week 2009 - (DGDispatch)
    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - (N Engl J Med)
    TopAbstracts in Diabetes 11/03/2009 - (DGNews)
    Paricalcitol Added to Hypertension Therapy Lowers Albuminuria in Patients With Diabetes and Chronic Kidney Disease: Presented at Renal Week 2009 - (DGDispatch)

    News archive

     Recent webcasts/CME - Diabetes
    • Optimizing Insulin-Dependent Diabetes Management in Long-Term Care
    • Insulin-Dependent Diabetes in Long-Term Care: Scope of the Problem and Effective Management
    • Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
      Diabetes Management - Pearls of Lipid Control
      Obesity Management in Patients with Type 2 Diabetes

      Webcasts/CME archive

       Recent cases - Diabetes
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy
        Compound Heterozygous Mutation of Aquaporin 2 Gene in Woman Patient with Congenital Nephrogenic Diabetes Insipidus

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Ginseng May Improve Glucose Control: Presented at ADA

        By Charlene Laino

        NEW ORLEANS, LA -- June 18, 2003 -- The finding that American ginseng may help to normalize blood glucose levels emphasizes the need to ask diabetic patients if they are taking any complementary medicines, Canadian researchers say.

        University of Toronto investigators spoke about the implications of their trial during a poster session here on June 14th at the 63rd Scientific Sessions of the American Diabetes Association's.

        The researchers enrolled 30 well-controlled type 2 diabetics into a double-blind, randomized, placebo-controlled, crossover-designed study.

        The participants, who were kept on their standard antidiabetic regimen of oral hypoglycemic agents or lifestyle intervention alone, were randomly assigned to receive either 3 g of ground-up North American–grown ginseng and 7 g of a highly viscous Konjac mannan fiber blend, or placebo, daily.

        After a 40-week run-in period, the patients were given one treatment for 12 weeks, followed by an 8-week wash-out period. Then, they were administered the alternate treatment for another 12 weeks.

        The average hemoglobin A1c (HbA1c) level fell from 7.0% at baseline to 6.5% when patients were taking the ginseng preparation, compared with 6.8% when they were taking placebo (p=0.006), the study showed.

        The results are comparable to those obtained with adjunct therapy with other hypoglycemic agents, such as the alpha-glucosidase inhibitors, in well-controlled patients, said Alexandra Jenkins, BSc, RD, a research associate at the University of Toronto, Canada.

        The herbal preparation appeared to be safe, with liver, kidney, and hemostatic function not adversely affected, compared with placebo, the study showed.

        Dr. Jenkins stressed that such a preliminary, short-term study is not a reason to recommend ginseng to patients.

        "We tried several [5] different sources of ginseng roots, testing them on ourselves, before finding one that seemed to have activity in regulating blood sugar," she said.

        Even if such a preparation was available at the health food store, there would be no way to know its purity due to poor regulation and labeling in the herbal industry, said John L. Sievenpiper, a PhD candidate at the University of Toronto and Dr. Jenkin's co-investigator.

        But, the findings give every reason to ask diabetic patients if they are taking ginseng or other complementary therapies, as standard medication dosing may need to be adjusted, he said.

        In a recent survey, physicians estimated that about 75% take complementary medicines, including herbs, Mr. Sievenpiper said.


        [Study title: Reduction of HbA1c after Long Term Administration of American Ginseng and Konjac Mannan Fiber in Type 2 Diabetes. Abstract 1676]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send